BusinessWire

Abartys Health Introduces PatientLynk 2.0 to Enable Universal Patient Identification, Provide Faster Response for COVID-19 Lab Tests

New platform follows policy change to offer quick test results and easy access to historical lab data

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Abartys Health, a healthcare data solutions company, today announces the launch of its PatientLynk 2.0. The platform, available on desktop and mobile, enables universal patient identification to provide faster response times for lab tests including COVID-19.


PatientLynk is designed specifically to improve patient access issues in accordance with new policy from The Centers for Medicare & Medicaid Services (CMS). The FHIR-compliant online platform provides real-time access to test results the moment they are reported, a feature of even greater importance in the new era of social distancing.

The U.S. healthcare system today is unable to provide the quick lab results required to make decisions about the critical care of COVID-19 patients. Even as rapid-results tests begin to work their way into clinics and labs, obtaining the results is a 24 hour or longer process.

Meanwhile, in March, CMS officially renewed its calls for driving interoperability and patient access to health information through liberating patient data. The ruling puts patients first, giving them access to their health information when they need it most and in a way they can best use it.

The policy change looks to break down barriers in the nation’s health system to enable better patient access to their health information, something which is vital in the fight against coronavirus. Many states are turning to call centers as a method for distributing results in the face of long wait times. However, this is a labor intensive and costly solution that also places at risk those working in call centers in the midst of a health pandemic.

“Using a patient portal to provide instant touchless results from the comfort of a patient’s home is the safest and best way to deliver test results during this time,” said Abartys Health co-founder Lauren Cascio.

“Abartys Health is focused on developing a patient-centric system that allows universal patient identification. In achieving this, patients are able to track, trend, and better understand their personal health regardless of the fragmented systems that were involved in processing their data.”

There are now coronavirus cases reported in every U.S. state. The pandemic exacerbates core inefficiencies in national healthcare like record inaccessibility and a lack of data portability. A survey last year found the healthcare industry is plagued by almost $1 trillion in waste each year – including up to $265.6 billion lost due to administrative complexity, $165.7 billion due to failure of care delivery, and $83.9 billion because of fraud.

“In this unprecedented moment, immediate access to lab tests for both patients and their loved ones has suddenly taken on an even greater importance,” explained Francisco Davila, Chief Medical Officer of Abartys Health. “PatientLynk fills a previously pressing – and now essential – need. And tech of this sort will help see us through these tough times.”

Increasingly in the last decade, the industry has been receptive to technology that can help solve these issues. Abartys Health, the winner of AOL Founder Steve Case’s recent competition, currently provides data solutions for seven major health insurers, optimizing medical solutions for more than 1.1 million patients and more than 14,000 doctors.

About Abartys Health

Founded in 2015, Abartys is working to solve the global healthcare crisis with smarter, faster care achieved by use of a unique, centralized data hub that allows for medical record portability and universal patient identification. Abartys has created a system that allows seamless data flow and communication between insurers, doctors, and patients with the goal of reducing the $750 billion annual loss in the U.S. healthcare market.


Contacts

Peter Andringa
1-646-480-0356
peter@publicize.co